Members of the Life Sciences section are involved in projects born under the umbrella of the European Network for Light Ion Therapy (ENLIGHT). These projects cover different aspects of hadron therapy for cancer treatment, from the development of appropriate instruments for a high-performance therapy to the training of young scientists.
ENVISION aims at developing solutions for real-time non invasive monitoring, quantitative imaging, precise determination of delivered dose, fast feedback for optimal treatment planning, real-time response to moving organs and simulation studies.
Launched in February 2010, ENVISION is a collaboration of sixteen leading European research centres and industrial partners, coordinated by CERN. The project is co-funded by the European Commission under the FP7 Cooperation Programme, under Grant Agreement N. 241851.
ULICE responds to the need for greater access to hadron-therapy facilities for particle therapy research, and addresses the development of appropriate instruments for high-performance hadron therapy, with particular emphasis on carbon ion therapy.
ULICE is set up by 20 leading European research organisations, including 2 leading European industrial partners, and is coordinated by CNAO (Pavia, Italy). The project started in 2009, and is co-funded by the European Commission within the FP7 Capacities Programme, under Grant Agreement no 228436.
PARTNER is a 4-year Marie Curie Initial Training Network aimed at the creation of the next generation of experts in hadron therapy. The project offers research and training opportunities to 25 young biologists, engineers, physicians and physicists and is allowing them to actively develop modern techniques for treating cancer in close collaboration with leading European Institutions
Ten academic institutes and research centres and two leading companies are participating in PARTNER, which was launched in 2008 and is coordinated by CERN. The project is funded by the European Commission under FP7 People (Marie Curie) Programme, under Grant Agreement No 215840.
ENTERVISION responds to the critical need for reinforcing research and training in online 3D digital imaging, in order to deliver some of the key elements for realizing the vision of early detection and more precise treatment of tumours. The project was launched in February 2011 and will provide training to sixteen young researchers in an interdisciplinary (physics, medicine, electronics, informatics, radiobiology, engineering) multinational network.
ENTERVISION brings together ten academic institutes and research centres of excellence and the two leading European companies in particle therapy, and is coordinated by CERN. The project is funded by the European Commission under FP7 People (Marie Curie) Programme, under Grant Agreement No 264552.